Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
IPO
Alerts
About
Mankind Pharma Ltd.
NSE: MANKIND
|
BSE: 543904
|
ISIN: INE634S01028
|
Industry: Pharmaceuticals
Analyst Downgrade
|
Expensive Performer
2364.9000
8.70
(
0.37
%)
NSE
Jun 17, 2026
15:07 PM
Volume:
117.8K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Mankind Pharma Ltd.
21 May 2026
Analyst Downgrade
2364.90
0.37%
BP Equities Q4FY26 Result Update Mankind Pharma Ltd.
Results Update:
Mankind Pharma Ltd.
by
BP Wealth
BP Wealth
...
Number of FII/FPI investors decreased from 575 to 568 in Mar 2026 qtr
More from Mankind Pharma Ltd.
Recommended
Market trades higher, India's defence production rises 15.6% in FY26
Trendlyne Marketwatch |
17 Jun 2026, 03:03PM
Five stocks to buy from analysts this week - June 16, 2026
The Baseline |
16 Jun 2026, 05:11PM
IPO momentum continues with six new issues and three upcoming listings
|
15 Jun 2026, 04:48PM